Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression1

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Immunology

• Publication date

  2008-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.180.11.7249PMID 18490724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epstein‐Barr virus latent membrane protein 1 promotes concentration in multivesicular bodies of fibroblast growth factor 2 and its release through exosomes

  2007cited by this paper
• Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.

  2007cited by this paper
• Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane

  2006cited by this paper
• Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function1

  2006cited by this paper
• ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15.

  2006cited by this paper
• Proteolytic release of soluble UL16-binding protein 2 from tumor cells.

  2006cited by this paper
• Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion.

  2006cited by this paper
• Vγ9Vδ2 T Cell Response to Colon Carcinoma Cells1

  2005cited by this paper
• Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects

  2005influential reference
• Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancer.

  2005cited by this paper
• Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells.

  2005cited by this paper
• ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming.

  2005cited by this paper
• Induction of heat shock proteins in B-cell exosomes

  2005cited by this paper
• NKG2D-independent suppression of T cell proliferation by H60 and MICA.

  2005cited by this paper
• The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

  2005cited by this paper
• Systemic NKG2D Down-Regulation Impairs NK and CD8 T Cell Responses In Vivo1

  2005cited by this paper
• NKG2D function protects the host from tumor initiation

  2005cited by this paper
• Silencing Human NKG2D, DAP10, and DAP12 Reduces Cytotoxicity of Activated CD8+ T Cells and NK Cells1

  2005cited by this paper
• More Efficient Induction of HLA-A*0201-Restricted and Carcinoembryonic Antigen (CEA)–Specific CTL Response by Immunization with Exosomes Prepared from Heat-Stressed CEA-Positive Tumor Cells

  2005cited by this paper
• Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer.

  2004cited by this paper
• Exosomes as Potent Cell-Free Peptide-Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I/Peptide Complexes to Dendritic Cells 1

  2004cited by this paper
• Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells.

  2004cited by this paper
• Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients1

  2004cited by this paper
• Proteomic analysis of exosomes isolated from human malignant pleural effusions.

  2004cited by this paper
• Cutting Edge: Novel Priming of Tumor-Specific Immunity by NKG2D-Triggered NK Cell-Mediated Tumor Rejection and Th1-Independent CD4+ T Cell Pathway1

  2004cited by this paper
• Exosomes as Potent Cell-Free Peptide-Based Vaccine. II. Exosomes in CpG Adjuvants Efficiently Prime Naive Tc1 Lymphocytes Leading to Tumor Rejection 1

  2004cited by this paper
• Adhesion and signaling by B cell‐derived exosomes: the role of integrins

  2004cited by this paper
• Elevated TGF-b1 Secretion and Downmodulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients

  2004cited by this paper
• Direct stimulation of naïve T cells by membrane vesicles from antigen-presenting cells: Distinct roles for CD54 and B7 molecules

  2003cited by this paper
• Lipid raft-associated protein sorting in exosomes.

  2003cited by this paper
• Antigen‐presenting cell exosomes are protected from complement‐mediated lysis by expression of CD55 and CD59

  2003cited by this paper
• Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

  2002influential reference
• Production and characterization of clinical grade exosomes derived from dendritic cells.

  2002cited by this paper
• Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles

  2002cited by this paper
• A cautionary note on experimental artefacts induced by fetal calf serum in a viral model of pulmonary eosinophilia.

  2002cited by this paper
• Malignant effusions and immunogenic tumour-derived exosomes.

  2002influential reference
• Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

  2001cited by this paper
• Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin

  2001cited by this paper
• Direct Immunosuppressive Effects of EBV-Encoded Latent Membrane Protein 1

  2000cited by this paper
• Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.

  1999cited by this paper
• Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes

  1998cited by this paper
• B lymphocytes secrete antigen-presenting vesicles

  1996cited by this paper
• Exosome formation during maturation of mammalian and avian reticulocytes: Evidence that exosome release is a major route for externalization of obsolete membrane proteins

  1991cited by this paper

• The immunosuppressive role of HLA-G+ extracellular vesicles in bone marrow of infiltrating tumors: The lesson learned from neuroblastoma and multiple myeloma.

  2026cites this paper
• Potential role of exosomes derived from the tumor microenvironment in tumor progression and treatment.

  2026cites this paper
• Targeting NKG2DLs with an ADCC enhanced fusion protein for induction of NK cell reactivity against ovarian cancer

  2026cites this paper
• Targeting NKG2D/NKG2DL axis in cancer immunotherapy: mechanisms and therapeutic applications

  2026cites this paper
• Enhanced Natural Killer Cell Proliferation by Stress‐Induced Feeder Cells

  2025cites this paper
• CAR Beyond αβ T Cells: Unleashing NK Cells, Macrophages, and γδ T Lymphocytes Against Solid Tumors

  2025cites this paper
• NKp30 and NKG2D contribute to natural killer cell-mediated recognition of HIV-infected cells

  2025cites this paper
• Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies

  2025cites this paper
• New insights into extracellular vesicles in metastatic cancer: From mechanisms to diagnostics and targeted therapies

  2025cites this paper
• Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth

  2025cites this paper
• Role of tumor-derived exosomes and immune cells in osteosarcoma progression and targeted therapy

  2025cites this paper
• Dysregulation of the Bone Marrow Microenvironment in Pediatric Tumors: The Role of Extracellular Vesicles in Acute Leukemias and Neuroblastoma

  2025cites this paper
• Extracellular vesicles in cancer´s communication: messages we can read and how to answer

  2025cites this paper
• 23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation

  2025cites this paper
• HBV-associated hepatocellular carcinomas inhibit antitumor CD8+ T cell via the long noncoding RNA HDAC2-AS2

  2025cites this paper
• Cancer-derived extracellular vesicles in natural killer cell immune evasion: molecular mechanisms and therapeutic insights.

  2025cites this paper
• Functional role of cancer stem cell like exosomes on survival and drug resistance behaviors of colorectal cancer cells

  2025cites this paper
• La citocina TGF-β y su papel en la comunicación intercelular en el microambiente tumoral: Mecanismos de síntesis, secreción, activación y acción

  2025cites this paper
• The Role of Small Extracellular Vesicles in Tumor Development and the Prospect of Targeted Therapy

  2025cites this paper
• Tumor-infiltrating lymphocytes and tumor-associated macrophages in cancer immunoediting: a targetable therapeutic axis

  2025cites this paper
• Biomarkers in Localized Prostate Cancer: From Diagnosis to Treatment

  2025influential citation
• The role of exosomes in immunopathology and potential therapeutic implications

  2025cites this paper
• Extracellular Vesicles in Cancer Immunotherapy: Therapeutic, Challenges and Clinical Progress

  2025cites this paper
• Exosomes: a potential tool in the diagnosis, prognosis and treatment of patients with colorectal cancer.

  2025cites this paper
• Emerging cell-based and cell-free therapeutic strategies for vitiligo

  2025cites this paper
• GC-derived exosomal circMAN1A2 promotes cancer progression and suppresses T-cell antitumour immunity by inhibiting FBXW11-mediated SFPQ degradation

  2025cites this paper
• A review of the role of tumor-derived exosomes in cancers treatment and progression.

  2025cites this paper
• NKG2D triggering hampers DNAM-1-mediated signaling in human NK cells

  2025cites this paper
• Extracellular vesicles in tumor immunity: mechanisms and novel insights

  2025cites this paper
• Exosome-Mediated Crosstalk Between Cancer Cells and Tumor Microenvironment

  2025cites this paper
• Cancer-derived exosomes as novel biomarkers in metastatic gastrointestinal cancer

  2024cites this paper
• Small extracellular vesicles: multi-functional aspects in non-small cell lung carcinoma.

  2024cites this paper
• Breakthrough of solid tumor treatment: CAR-NK immunotherapy

  2024cites this paper
• The Triple Adipose-Derived Stem Cell Exosome Technology as a Potential Tool for Treating Triple-Negative Breast Cancer

  2024cites this paper
• Extracellular vesicle-mediated communication between CD8+ cytotoxic T cells and tumor cells

  2024cites this paper
• Therapeutic potential of exosomes derived from mesenchymal stem cells for treatment of systemic lupus erythematosus

  2024cites this paper
• Recent Progress in the Application of Exosome Analysis in Ovarian Cancer Management.

  2024cites this paper
• Unlocking the potential of exosomes in cancer research: A paradigm shift in diagnosis, treatment, and prevention.

  2024cites this paper
• The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia

  2024cites this paper
• Endometriotic Tissue-derived Exosomes Downregulate NKG2D-mediated Cytotoxicity and Promote Apoptosis: Mechanisms for Survival of Ectopic Endometrial Tissue in Endometriosis.

  2024cites this paper
• Cell Type-Specific Extracellular Vesicles and Their Impact on Health and Disease

  2024cites this paper
• Tumor Microenvironment Modulation by Cancer-Derived Extracellular Vesicles

  2024cites this paper
• Construction of a prognostic model with exosome biogenesis- and release-related genes and identification of RAB27B in immune infiltration of pancreatic cancer

  2024cites this paper
• Focusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy

  2024cites this paper
• Tumor Microenvironment-Derived Exosomes: A Double-Edged Sword for Advanced T Cell-Based Immunotherapy.

  2024cites this paper
• Exploring the landscape of Lipid Nanoparticles (LNPs): A comprehensive review of LNPs types and biological sources of lipids

  2024cites this paper
• Exosomes as carriers to stimulate an anti-cancer immune response in immunotherapy and as predictive markers.

  2024cites this paper
• Engineered exosomes in service of tumor immunotherapy: From optimizing tumor‐derived exosomes to delivering CRISPR/Cas9 system

  2024cites this paper
• Insights in AAV-mediated antigen-specific immunity and a strategy for AAV vaccine dose reduction through AAV-extracellular vesicle association

  2024cites this paper
• The role of extracellular vesicles in cholangiocarcinoma tumor microenvironment

  2024cites this paper
• Unveiling exosomes: Cutting‐edge isolation techniques and their therapeutic potential

  2024cites this paper
• Non-neoplastic astrocytes: key players for brain tumor progression

  2024cites this paper
• Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies

  2024cites this paper
• Tumor‐associated exosomes in cancer progression and therapeutic targets

  2024cites this paper
• Biogenesis and functional implications of extracellular vesicles in cancer metastasis

  2024cites this paper
• Exosome nanovesicles: biomarkers and new strategies for treatment of human diseases

  2024cites this paper
• NKp30 and NKG2D contribute to natural killer recognition of HIV-infected cells

  2024cites this paper
• Advancements in Personalized CAR-T Therapy: Comprehensive Overview of Biomarkers and Therapeutic Targets in Hematological Malignancies

  2024cites this paper
• Small Extracellular Vesicles Promote Stiffness-mediated Metastasis

  2024cites this paper
• CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY: HARNESSING EXTRACELLULAR VESICLES FOR ENHANCED EFFICACY.

  2024cites this paper
• Exosomes in diagnostic and therapeutic applications of ovarian cancer

  2024cites this paper
• The implications of exosomes in psoriasis: disease: emerging as new diagnostic markers and therapeutic targets

  2024cites this paper
• Exosomal Signaling in Cancer Metastasis: Molecular Insights and Therapeutic Opportunities.

  2024cites this paper
• Exosomes: The Role in Tumor Tolerance and the Potential Strategy for Tumor Therapy

  2023cites this paper
• Small extracellular vesicles promote stiffness-mediated metastasis

  2023cites this paper
• Non-Coding RNAs Derived from Extracellular Vesicles Promote Pre-Metastatic Niche Formation and Tumor Distant Metastasis

  2023cites this paper
• Understanding exosomes: Part 1-Characterization, quantification and isolation techniques.

  2023cites this paper
• The role of extracellular vesicles in circulating tumor cell-mediated distant metastasis

  2023cites this paper
• Engineering of Trophoblast Extracellular Vesicle-Delivering Hydrogels for Localized Tolerance Induction in Cell Transplantation

  2023cites this paper
• Extracellular Vesicles as Next Generation Immunotherapeutics.

  2023cites this paper
• Theranostic signature of tumor-derived exosomes in cancer

  2023cites this paper
• Exosomal miRNAs and breast cancer: a complex theranostics interlink with clinical significance

  2023cites this paper
• New Possible Ways to Use Exosomes in Diagnostics and Therapy via JAK/STAT Pathways

  2023cites this paper
• Tumor-derived nanoseeds condition the soil for metastatic organotropism.

  2023cites this paper
• Tumour‑derived exosomes and their emerging roles in leukaemia (Review)

  2023cites this paper
• Small extracellular vesicle TGF-β in cancer progression and immune evasion

  2023influential citation
• The tumor immune microenvironment in pancreatic cancer and its potential in the identification of immunotherapy biomarkers

  2023cites this paper
• Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology

  2023cites this paper
• Extracellular Vesicles: New Classification and Tumor Immunosuppression

  2023cites this paper
• Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients

  2023cites this paper
• Killer instincts: natural killer cells as multifactorial cancer immunotherapy

  2023cites this paper
• Machine learning-based analysis of cancer cell-derived vesicular proteins revealed significant tumor-specificity and predictive potential of extracellular vesicles for cell invasion and proliferation – A meta-analysis

  2023cites this paper
• The Role of Exosomes in the Progression and Therapeutic Resistance of Hematological Malignancies

  2022cites this paper
• Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy

  2022cites this paper
• Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression

  2022cites this paper
• CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity

  2022cites this paper
• Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications

  2022cites this paper
• LncRNA Biomarkers of Inflammation and Cancer.

  2022cites this paper
• Brain organoid-on-chip system to study the effects of breast cancer derived exosomes on the neurodevelopment of brain

  2022cites this paper
• Exosomes for Regulation of Immune Responses and Immunotherapy

  2022cites this paper
• Pioneer Role of Extracellular Vesicles as Modulators of Cancer Initiation in Progression, Drug Therapy, and Vaccine Prospects

  2022cites this paper
• Tumor-derived exosomes: immune properties and clinical application in lung cancer

  2022cites this paper
• Modified dendritic cell-derived exosomes activate both NK cells and T cells through the NKG2D/NKG2D-L pathway to kill CML cells with or without T315I mutation

  2022cites this paper
• Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1

  2022cites this paper
• Exploring the role of extracellular vesicles and their protein cargo in lung cancer metastasis: a review.

  2022cites this paper
• Exosome Processing and Characterization Approaches for Research and Technology Development

  2022cites this paper
• Identification of an exosome-related signature associated with prognosis and immune infiltration in breast cancer

  2022cites this paper
• Impact on NK cell functions of acute versus chronic exposure to extracellular vesicle‐associated MICA: Dual role in cancer immunosurveillance

  2022cites this paper
• miR-221-5p and miR-186-5p Are the Critical Bladder Cancer Derived Exosomal miRNAs in Natural Killer Cell Dysfunction

  2022cites this paper
• Effects of Circulating Exosomes on B cells in Head and Neck Squamous Cell Carcinoma

  2022influential citation